Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.
Clinical trial NCT01789281 · COMPLETED
Trial details
- NCT number
- NCT01789281
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-14
- Primary completion
- 2020-08-28
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.